Clinical Trial Update: Effect of Single Dose Intranasal Insulin On Cognitive Function [Phase 4]

View source ↗

Summary

Update on a Phase 4 trial evaluating whether a single dose of intranasal insulin improves cognitive function in schizophrenia and schizoaffective disorder; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-01-29